B

Biodyne Co Ltd
KOSDAQ:314930

Watchlist Manager
Biodyne Co Ltd
KOSDAQ:314930
Watchlist
Price: 16 470 KRW -6.79% Market Closed
Market Cap: 485.5B KRW
Have any thoughts about
Biodyne Co Ltd?
Write Note

Net Margin
Biodyne Co Ltd

-21.3%
Current
-69%
Average
2.2%
Industry

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
-21.3%
=
Net Income
-892.8m
/
Revenue
4.2B

Net Margin Across Competitors

Country KR
Market Cap 485.5B KRW
Net Margin
-21%
Country US
Market Cap 204.9B USD
Net Margin
14%
Country US
Market Cap 195.2B USD
Net Margin
29%
Country US
Market Cap 146.7B USD
Net Margin
16%
Country US
Market Cap 132.6B USD
Net Margin
11%
Country IE
Market Cap 110.6B USD
Net Margin
12%
Country US
Market Cap 64.7B USD
Net Margin
9%
Country DE
Market Cap 55.6B EUR
Net Margin
8%
Country CN
Market Cap 319.2B CNY
Net Margin
34%
Country US
Market Cap 41.6B USD
Net Margin
74%
Country US
Market Cap 37.7B USD
Net Margin
9%
No Stocks Found

Biodyne Co Ltd
Glance View

Market Cap
485.5B KRW
Industry
Health Care

Biodyne Co., Ltd. engages in the development of cancer diagnosis solutions. The company is headquartered in Seoul, Seoul and currently employs 26 full-time employees. The company went IPO on 2021-03-17. The firm produces and sells LBC diagnostic equipment and diagnostic reagent kits. The firm's LBC equipment include PATHPLORER AUTO, PATHPLORER 4.7, PATHPLORER 4.63 and PATHPLORER ECO. The firm sells its products in domestic and overseas markets such as Japan, Russia, Portugal and Thailand.

Intrinsic Value
489.78 KRW
Overvaluation 97%
Intrinsic Value
Price
B

See Also

Discover More
What is Net Margin?

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
-21.3%
=
Net Income
-892.8m
/
Revenue
4.2B
What is the Net Margin of Biodyne Co Ltd?

Based on Biodyne Co Ltd's most recent financial statements, the company has Net Margin of -21.3%.